Contact
searchSearch
HMP Global

Peripheral Arterial Disease: Features

Interview
Sirolimus-Eluting Bioresorbable Scaffolds for Femoropopliteal Disease: Early Findings From EFEMORAL I
09/16/2026
Ramon L. Varcoe, MBBS, MS, PhD
Dr Ramon Varcoe discusses early experience with the investigational Efemoral Vascular Scaffold System.
Dr Ramon Varcoe discusses early experience with the investigational Efemoral Vascular Scaffold System.
Dr Ramon Varcoe discusses early...
09/16/2026
Vascular Disease Management
Case Report
Restoring Mobility in Complex Diabetic Peripheral Arterial Disease
09/15/2026
Stavros Spiliopoulos, MD, PhD; Stavros Grigoriadis, MD, MSc, PhD; Konstantinos Palialexis, MD, MSc, PhD; Constantine N. Antonopoulos, MD, PhD; George S. Sfyroeras, MD, PhD
A 72-year-old woman with a 10-year history of type 2 DM, arterial hypertension, and hyperlipidemia presented with longstanding lower-extremity IC affecting her left leg.
A 72-year-old woman with a 10-year history of type 2 DM, arterial hypertension, and hyperlipidemia presented with longstanding lower-extremity IC affecting her left leg.
A 72-year-old woman with a...
09/15/2026
Vascular Disease Management
Dr Anahita Dua speaks at AMP 2026
AMP 2026
The Changing Face of Chronic Limb-Threatening Ischemia: Global Epidemiology and the Untold Data Story
09/10/2026
Anahita Dua, MD, MS, MBA, FACS
Dr Anahita Dua discusses the changing face of CLTI.
Dr Anahita Dua discusses the changing face of CLTI.
Dr Anahita Dua discusses the...
09/10/2026
Vascular Disease Management
Review
SEISMIQ: The Next-Generation Intravascular Lithotripsy System
09/02/2026
Nicholas Petruzzi, MD, FSIR, FSVM, FAHA
This review summarizes results from the RESTORE ATK and RESTORE BTK studies, which looked at the safety and efficacy of the SEISMIQ IVL system (Boston Scientific).
This review summarizes results from the RESTORE ATK and RESTORE BTK studies, which looked at the safety and efficacy of the SEISMIQ IVL system (Boston Scientific).
This review summarizes results...
09/02/2026
Vascular Disease Management
Dr N'Dandu speaks at AMP 2026
AMP 2026
Woundosome for Wound Healing
09/01/2026
Zola N'Dandu, MD
Dr Zola N'Dandu discusses the woundosome concept and its impact on outcomes in patients with chronic limb-threatening ischemia.
Dr Zola N'Dandu discusses the woundosome concept and its impact on outcomes in patients with chronic limb-threatening ischemia.
Dr Zola N'Dandu discusses the...
09/01/2026
Vascular Disease Management
Marianne Brodmann, MD, speaks at AMP 2026.
AMP 2026
Long-Term Evidence From DEEPER OUS
08/25/2026
Marianne Brodmann, MD
Dr Marianne Brodmann discusses the latest results from the DEEPER OUS trial.
Dr Marianne Brodmann discusses the latest results from the DEEPER OUS trial.
Dr Marianne Brodmann discusses...
08/25/2026
Vascular Disease Management
Case Report
Revascularizing Femoropopliteal Chronic Total Occlusions With Atheroplasty: A Case-Based Discussion
08/13/2026
Michael Lichtenberg MD; Stefan Stahlhoff, MD
This case illustrates the application of the Santreva-ATK system (AngioSafe) in a complex femoropopliteal CTO.
This case illustrates the application of the Santreva-ATK system (AngioSafe) in a complex femoropopliteal CTO.
This case illustrates the...
08/13/2026
Vascular Disease Management
Review
Safety of Outpatient Endovascular Interventions for Peripheral Arterial Disease: Evidence and Applications for U.S. Practice
08/12/2026
Naina G. Subherwal; Simran P. Subherwal; Sreejit Nair, MD; Ashwani Sastry, MD
This review synthesized 31 studies (99,600 day case procedures; 2000-2024) plus U.S. registries and real-world cohorts evaluating outpatient peripheral endovascular intervention (PVI) for peripheral arterial disease.
This review synthesized 31 studies (99,600 day case procedures; 2000-2024) plus U.S. registries and real-world cohorts evaluating outpatient peripheral endovascular intervention (PVI) for peripheral arterial disease.
This review synthesized 31...
08/12/2026
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

TARE vs TACE
TARE Improves Outcomes vs TACE for Large Unresectable HCC
09/14/2026
Laura Simson, MA
A 2026 retrospective study of patients with solitary unresectable hepatocellular carcinoma found that transarterial radioembolization was associated with longer adjusted overall survival and local progression-free survival than transarterial...
A 2026 retrospective study of patients with solitary unresectable hepatocellular carcinoma found that transarterial radioembolization was associated with longer adjusted overall survival and local progression-free survival than transarterial...
A 2026 retrospective study of...
09/14/2026
Vascular Disease Management
Medicare Reimbursement
CMS Approves New Technology Add-on Payment for Reflow Medical’s Spur® Peripheral Retrievable Stent System
09/01/2026
SAN CLEMENTE, CA – September 1, 2026 – Reflow Medical, Inc. announced that the Centers for Medicare & Medicaid Services (CMS) has granted the Spur Peripheral Retrievable Stent System a New Technology Add-on Payment (NTAP), providing...
SAN CLEMENTE, CA – September 1, 2026 – Reflow Medical, Inc. announced that the Centers for Medicare & Medicaid Services (CMS) has granted the Spur Peripheral Retrievable Stent System a New Technology Add-on Payment (NTAP), providing...
SAN CLEMENTE, CA – September 1,...
09/01/2026
Vascular Disease Management
Pulmonary Embolism
PRAGUE-26 Trial: Evaluating Catheter-Directed Thrombolysis for Intermediate-High Risk Pulmonary Embolism Patients Versus Standard Anticoagulation Therapy Alone
09/01/2026
“The academic PRAGUE-26 trial aimed to challenge the current standard of care in intermediate–high risk acute pulmonary embolism by determining whether conventional CDT (without ultrasound facilitation) can improve on anticoagulation...
“The academic PRAGUE-26 trial aimed to challenge the current standard of care in intermediate–high risk acute pulmonary embolism by determining whether conventional CDT (without ultrasound facilitation) can improve on anticoagulation...
“The academic PRAGUE-26 trial...
09/01/2026
Cath Lab Digest
NYU Langone
NYU Langone Names Sunil Rao, MD, Director of the Leon H. Charney Division of Cardiology and Welcomes Susheel Kodali, MD, to Lead Interventional Cardiology
08/27/2026
NYU Langone Health has appointed Sunil Rao, MD, an internationally recognized clinician-investigator whose work has introduced new approaches to treating patients with complex cardiovascular conditions, as director of the Leon H. Charney...
NYU Langone Health has appointed Sunil Rao, MD, an internationally recognized clinician-investigator whose work has introduced new approaches to treating patients with complex cardiovascular conditions, as director of the Leon H. Charney...
NYU Langone Health has appointed...
08/27/2026
Vascular Disease Management
Bioresorbable Scaffolds
Abbott Secures CE Mark for Longer-Length Esprit BTK System for Severe PAD in Europe
08/26/2026
The longer-length Esprit addresses a real-world clinical need: most below-the-knee lesions in CLTI patients exceed 100 mm, while existing lengths can require multiple scaffolds, increasing procedural time and complexity.
The longer-length Esprit addresses a real-world clinical need: most below-the-knee lesions in CLTI patients exceed 100 mm, while existing lengths can require multiple scaffolds, increasing procedural time and complexity.
The longer-length Esprit...
08/26/2026
Cath Lab Digest
Radiation Safety
Radiation Detection Company Introduces Radiant, Expanding Real-Time Radiation Safety for High-Exposure Clinical Environments
08/20/2026
Radiation Detection Company (RDC) launched Radiant real-time dosimetry, a connected electronic dosimetry solution designed to provide clinicians with immediate visibility into radiation levels during high-exposure medical procedures.
Radiation Detection Company (RDC) launched Radiant real-time dosimetry, a connected electronic dosimetry solution designed to provide clinicians with immediate visibility into radiation levels during high-exposure medical procedures.
Radiation Detection Company...
08/20/2026
Cath Lab Digest
Imaging of acute ischemic stroke
Stroke Treatment
Siemens Healthineers Receives ARPA-H Funding of up to $31M to Advance Remote Endovascular Robotics for Acute Stroke Treatment
08/20/2026
The technology has the potential to enable autonomous remote treatment of acute ischemic stroke through mechanical thrombectomy without direct human input. Autonomous remote endovascular robotics(1) can help to get the right treatment faster...
The technology has the potential to enable autonomous remote treatment of acute ischemic stroke through mechanical thrombectomy without direct human input. Autonomous remote endovascular robotics(1) can help to get the right treatment faster...
The technology has the potential...
08/20/2026
Cath Lab Digest
Radiation-Reducing Tech
Hoag First in California to Bring Radiation-Reducing Technology to Complex Vascular Care
08/18/2026
Patients undergoing complex aortic aneurysm repair at Hoag now have access to one of the most advanced image-guided technologies available.
Patients undergoing complex aortic aneurysm repair at Hoag now have access to one of the most advanced image-guided technologies available.
Patients undergoing complex...
08/18/2026
Vascular Disease Management
pVasc NET (Vesalio)
Thrombectomy
Vesalio Announces FDA 510(k) Clearance of pVasc NET, a Next-Generation Peripheral Mechanical Thrombectomy Device With Integrated Distal Filter
08/17/2026
New device expands Vesalio’s pVasc platform with integrated clot-capture technology designed to retain clot fragments during retrieval.
New device expands Vesalio’s pVasc platform with integrated clot-capture technology designed to retain clot fragments during retrieval.
New device expands Vesalio’s...
08/17/2026
Cath Lab Digest
JANE-2 project
Green Paper
Tumor Ablation Review Maps Next Phase of Cancer Care
08/14/2026
Laura Simson, MA
The EU Joint Action Networks of Expertise on Cancer (JANE-2) green paper examines emerging applications and strategies for integrating physical tumor ablation methods into oncology care.
The EU Joint Action Networks of Expertise on Cancer (JANE-2) green paper examines emerging applications and strategies for integrating physical tumor ablation methods into oncology care.
The EU Joint Action Networks of...
08/14/2026
Vascular Disease Management

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use